Emerging anticarcinogenic effects of fluoxetine besides its role in the treatment of breast carcinomas.
I read with great interest the recent article by Zhou et al. in a recent issue of your esteemed journal. The article is highly thought provoking. Interestingly, over the past few years, new data has emerged that reveals the emerging anticarcinogenic role of fluoxetine in systemic tumors besides breast carcinomas.
shailendrakapoor@yahoo.com
Shailendra
S
Kapoor
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000378:metabolism*; D019008:Drug Resistance, Neoplasm; D005260:Female; D005473:Fluoxetine / Q000494:pharmacology*; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors